TrialNature nanotechnology2024

First-in-human controlled inhalation of thin graphene oxide nanosheets to study acute cardiorespiratory responses.

Jack P M Andrews et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.